We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-12.02%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$407M
AUM Growth
-$58.3M
Cap. Flow
+$45.4M
Cap. Flow %
11.18%
Top 10 Hldgs %
95.66%
Holding
22
New
4
Increased
8
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$4.52M
2
OPK icon
Opko Health
OPK
+$4.34M
3
AGEN
Agenus
AGEN
+$1.09M
4
ATRS
Antares Pharma, Inc.
ATRS
+$949K
5
DERM
Dermira, Inc.
DERM
+$615K

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$4.67M
2
AMRN
Amarin Corp
AMRN
+$1.62M
3
CFRX
ContraFect Corporation
CFRX
+$826K
4
AXDX
Accelerate Diagnostics
AXDX
+$159K
5
QDEL icon
QuidelOrtho
QDEL
+$48.1K

Sector Composition

Rank Sector Weight
1 Healthcare 96.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QDEL icon
1
QuidelOrtho
QDEL
$1.14B
$109M 26.93%
1,784,464
-800
-0% -$48.1K
AXDX
2
DELISTED
Accelerate Diagnostics
AXDX
$80.7M 19.86%
434,814
-822
-0.2% -$159K
AMRN
3
Amarin Corp
AMRN
$293M
$76.3M 18.78%
251,811
-4,638
-2% -$1.62M
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$74.3M 18.26%
1,779,875
+106,925
+6% +$4.52M
OPK icon
5
Opko Health
OPK
$1.25B
$12.1M 2.99%
5,810,376
+2,124,182
+58% +$4.34M
DERM
6
DELISTED
Dermira, Inc.
DERM
$11.7M 2.88%
1,833,785
+73,713
+4% +$615K
MOTS
7
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$7.54M 1.85%
12,689
+133
+1% +$108K
SLNO
8
DELISTED
Soleno Therapeutics
SLNO
$5.81M 1.43%
258,042
+3,805
+1% +$121K
PACB icon
9
Pacific Biosciences
PACB
$432M
$5.73M 1.41%
1,110,666
– –
VRML
10
DELISTED
Vermillion, Inc.
VRML
$5.13M 1.26%
9,825,289
– –
BIOL
11
DELISTED
Biolase, Inc.
BIOL
$4.86M 1.2%
2,069
– –
AGEN
12
Agenus
AGEN
$275M
$4.67M 1.15%
92,133
+20,349
+28% +$1.09M
BHVN
13
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.81M 0.44%
+126,400
New +$5.34M
CFRX
14
DELISTED
ContraFect Corporation
CFRX
$1.57M 0.39%
5,491
-2,455
-31% -$826K
BIIB icon
15
Biogen
BIIB
$30.4B
$1.48M 0.36%
6,368
– –
BHVN
16
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$966K 0.24%
596,000
+137,200
+30% +$5.8M
ATRS
17
DELISTED
Antares Pharma, Inc.
ATRS
$964K 0.24%
+288,237
New +$949K
AXDX
18
CALL
DELISTED
Accelerate Diagnostics
AXDX
$687K 0.17%
90,010
+72,010
+400% +$13.9M
QDEL icon
19
CALL
QuidelOrtho
QDEL
$1.14B
$490K 0.12%
+73,900
New +$4.45M
AMRN
20
CALL
Amarin Corp
AMRN
$293M
$108K 0.03%
6,000
-26,535
-82% -$9.26M
XBI icon
21
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$51K 0.01%
+250,000
New +$20.8M
CI icon
22
Cigna
CI
$79.6B
– –
-29,653
Closed -$4.67M

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, Oracle Investment Management held 22 positions worth $407M, down 13% from $465M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Oracle Investment Management deployed $45.4M of net new capital in Q3 2019, opening 4 new positions and adding to 8 existing holdings. Its largest new stake was Antares Pharma, Inc.: 288,237 shares worth $964K.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier.

On the sell side, the largest reduction was Amarin Corp, an estimated $1.62M trimmed.

  • Oracle Investment Management's largest Q3 2019 buy was Antares Pharma, Inc.: 288,237 shares worth $964K.
  • Oracle Investment Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019, an estimated $4.52M increase.
  • Oracle Investment Management's biggest Q3 2019 reduction was Amarin Corp, cutting an estimated $1.62M.
  • Oracle Investment Management fully exited Cigna in Q3 2019, selling an estimated $4.67M.
  • Oracle Investment Management's ten largest holdings make up 96% of its $407M portfolio in Q3 2019.
  • Oracle Investment Management opened 4 new positions and closed 1 in Q3 2019.
  • Oracle Investment Management's portfolio value fell 13% quarter-over-quarter to $407M.

Based on Oracle Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.